- Home
- CLLS vs CIK Comparison
CLLS vs CIK Comparison
Compare CLLS & CIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- CIK
- Stock Information
- Founded
- CLLS 1999
- CIK 1987
- Country
- CLLS France
- CIK United States
- Employees
- CLLS N/A
- CIK N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- CIK Finance/Investors Services
- Sector
- CLLS Health Care
- CIK Finance
- Exchange
- CLLS Nasdaq
- CIK Nasdaq
- Market Cap
- CLLS 148.1M
- CIK 159.3M
- IPO Year
- CLLS 2007
- CIK N/A
- Fundamental
- Price
- CLLS $1.53
- CIK $2.95
- Analyst Decision
- CLLS Buy
- CIK
- Analyst Count
- CLLS 3
- CIK 0
- Target Price
- CLLS $7.00
- CIK N/A
- AVG Volume (30 Days)
- CLLS 114.3K
- CIK 115.4K
- Earning Date
- CLLS 11-04-2024
- CIK 01-01-0001
- Dividend Yield
- CLLS N/A
- CIK 9.03%
- EPS Growth
- CLLS N/A
- CIK N/A
- EPS
- CLLS N/A
- CIK N/A
- Revenue
- CLLS $36,042,000.00
- CIK N/A
- Revenue This Year
- CLLS $387.77
- CIK N/A
- Revenue Next Year
- CLLS $11.14
- CIK N/A
- P/E Ratio
- CLLS N/A
- CIK N/A
- Revenue Growth
- CLLS 46.96
- CIK N/A
- 52 Week Low
- CLLS $1.41
- CIK $2.50
- 52 Week High
- CLLS $3.38
- CIK $3.19
- Technical
- Relative Strength Index (RSI)
- CLLS 45.06
- CIK 50.60
- Support Level
- CLLS $1.51
- CIK $2.92
- Resistance Level
- CLLS $1.62
- CIK $2.98
- Average True Range (ATR)
- CLLS 0.09
- CIK 0.03
- MACD
- CLLS 0.01
- CIK -0.00
- Stochastic Oscillator
- CLLS 29.17
- CIK 33.33
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
About CIK Credit Suisse Asset Management Income Fund Inc.
Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. Credit Suisse serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations, and individuals.